BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:12 PM
 | 
Oct 09, 2009
 |  BC Extra  |  Clinical News

Pfizer halts figitumumab Phase III

Pfizer (NYSE:PFE) said it temporarily halted new patient enrollment in the open-label Phase III ADVIGO 1016 trial to treat advanced non-adenocarcinoma non-small cell...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >